Mitokinin, Inc.
Biotechnology company · New York, United States
Mitokinin, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $225,000 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2018.
Mitokinin at a glance
What does Mitokinin do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $225,000 in total (2018). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $5 million sold (2018).
Frequently asked questions about Mitokinin
Where is Mitokinin headquartered?
Mitokinin, Inc. is headquartered in New York, United States.
What does Mitokinin do?
Mitokinin, Inc. is a biotechnology company.
When was Mitokinin founded?
The earliest incorporation on record for Mitokinin, Inc. is in 2017, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences